+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 289 Pages
  • Global
From
Rare Hematology - Global Strategic Business Report - Product Thumbnail Image

Rare Hematology - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Antidotes Market Report 2025 - Product Thumbnail Image

Antidotes Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 230 Pages
  • Global
From
Liver Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Liver Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 49 Pages
  • Global
From
Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 64 Pages
  • Global
From
Rare Diseases Treatment Market Report 2025 - Product Thumbnail Image

Rare Diseases Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nasal Drug Delivery Technology Market Report 2025 - Product Thumbnail Image

Nasal Drug Delivery Technology Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rare Disease Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Rare Disease Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 131 Pages
  • Global
From
Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030 - Product Thumbnail Image

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

  • Report
  • January 2019
  • 230 Pages
  • Global
From
Viral Gastroenteritis Market Report 2025 - Product Thumbnail Image

Viral Gastroenteritis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Proteomics: Technologies and Global Markets - Product Thumbnail Image

Proteomics: Technologies and Global Markets

  • Report
  • December 2022
  • 384 Pages
  • Global
From
Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021 - Product Thumbnail Image

Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 131 Pages
  • Global
From
Tumor / Cancer Markers - Global Strategic Business Report - Product Thumbnail Image

Tumor / Cancer Markers - Global Strategic Business Report

  • Report
  • April 2025
  • 114 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment - Global Strategic Business Report - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neurofibromatoses Type I (Von Recklinghausen's Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 72 Pages
  • Global
From
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 283 Pages
  • Global
PharmSource - Bio/Pharma CapEx Trends - 2019 Edition - Product Thumbnail Image

PharmSource - Bio/Pharma CapEx Trends - 2019 Edition

  • Report
  • December 2019
  • 32 Pages
  • Global
From
Loading Indicator